Maze Therapeutics, Inc. ($MAZE)
Filing Information
| Accession Number | 0002050172-26-000017 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 20, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
45,000
Total Value
$892,739.29
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President, R&D & CMO | Common Stock | โ | Mar 20, 2026 | Exercise/Conversion | 15,000 | $10.42 | $156,300.00 | 15,000 | Direct | โ | View Details | |
President, R&D & CMO | Common Stock | โ | Mar 20, 2026 | Sale | 6,161 | $48.20 | $296,976.83 | 8,839 | Direct | โ | View Details | |
President, R&D & CMO | Common Stock | โ | Mar 20, 2026 | Sale | 3,795 | $49.32 | $187,168.64 | 5,044 | Direct | โ | View Details | |
President, R&D & CMO | Common Stock | โ | Mar 20, 2026 | Sale | 5,044 | $50.02 | $252,293.82 | 0 | Direct | โ | View Details | |
President, R&D & CMO | Stock Option (Right to Buy) | Derivative | Mar 20, 2026 | Exercise/Conversion | 15,000 | $0.00 | $0.00 | 252,407 | Direct | โ | View Details |